Printer Friendly

MERCK INTRODUCING NEW DRUG FOR SYMPTOMATIC BENIGN PROSTATE ENLARGEMENT

 MERCK INTRODUCING NEW DRUG FOR
 SYMPTOMATIC BENIGN PROSTATE ENLARGEMENT
 WEST POINT, Pa., June 20 /PRNewswire/ -- Merck & Co., Inc. (NYSE: MRK), today announced the introduction of Proscar(R) (finasteride), the first of a new class of prescription drugs to treat symptomatic benign prostate enlargement. The company said the product will be available in pharmacies in late July.
 Merck filed the New Drug Application for Proscar with the U.S. Food and Drug Administration on April 15, 1991.
 Merck is a worldwide, research-intensive health products company that discovers, develops, produces and markets human and animal health products and specialty chemicals.
 -0- 6/20/92
 /EDITOR'S NOTE: A national satellite press conference on Proscar will be held Monday, June 22, starting at 1 p.m., in the Jade Room of the Waldorf Astoria in New York City./
 /CONTACT: Jan D. Weiner (press), 215-661-6462 or home, 215-664- 8722, Gary M. Bruell, 215-661-7485 or home 215-368-7328 or David Halter, (analysts), 908-594-6883, home, 908-654-8792 or Jim Mckee, 908-594-5185, all of Merck/
 (MRK) CO: Merck, & Co., Inc., ST: Pennsylvania IN: MTC SU:


JP -- NYSA001 -- 2156 06/20/92 09:10 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jun 20, 1992
Words:184
Previous Article:CENVILL DEVELOPMENT CORP. ANNOUNCES SALE OF CERTAIN ASSETS TO CV REIT
Next Article:FLEET LAUNCHES FIRST-TIME HOMEBUYER PROGRAM
Topics:


Related Articles
FDA COMMITTEE FAVORABLY REVIEWS MERCK PROSTATE DRUG
/C O R R E C T I O N -- ROBERTS PHARMACEUTICALS/
PROSCAR, NEW DRUG FOR SYMPTOMATIC BENIGN PROSTATE ENLARGEMENT, INTRODUCED AT NATIONAL SATELLITE NEWS CONFERENCE TODAY, 1 P.M.
FIRST ADD TO MERCK ANNOUNCES PROGRAM FOR PATIENTS ON PROSCAR
FDA APPROVES PROSTATE DRUG
PROSCAR(R) NOW AVAILABLE IN U.S. PHARMACIES; NEW DRUG TREATS COMMON PROSTATE PROBLEM IN OLDER MEN
ABBOTT, MERCK AND VA TO FUND COOPERATIVE STUDY FOR THE TREATMENT OF BPH
MERCK'S PROSCAR BEING STUDIED IN VETERAN'S AFFAIRS TREATMENT TRIAL FOR SYMPTOMATIC BENIGN PROSTATE ENLARGEMENT
RECOGNIZING EXCELLENCE IN INNOVATION, IDENTIFYING HEROES; MERCK RESEARCHERS RECEIVE 1993 INVENTOR OF YEAR AWARD FOR BREAKTHROUGH DRUG
MERCK AND SYNAPTIC PHARMACEUTICAL CORPORATION SIGN RESEARCH COLLABORATION AND LICENSE AGREEMENT

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters